Shortlisted for: Popular Non-Fiction Book of the Year - Specsavers National Book Awards 2012
'Bad Science' hilariously exposed the tricks that quacks and journalists use to distort science, becoming a 400,000 copy bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess.
Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry.
The pharmaceutical industry spends more on marketing than it does on research and development. New diseases are invented in order to swell profits. It distorts and suppresses the results of clinical trials if they are unfavourable. Patients' pressure groups are covertly sponsored by pill manufacturers. Its offences are countless and the consequences are felt by us all. What we trust to cure us may be ineffectual or actually harmful. Patients are harmed in huge numbers.
Ben Goldacre is Britain's finest writer on the science behind medicine, and 'Bad Pharma' is a clear and witty attack, showing exactly how the science has been distorted, how our systems have been broken, and how easy it would be to fix them.